Covered recipient · General Payments record
CARMEN CORONA ZAVALA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$308.03
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $308.03 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $54.56 | 3 |
| E.R. Squibb & Sons, L.L.C. | $51.17 | 2 |
| UCB, Inc. | $50.64 | 3 |
| ABBVIE INC. | $43.17 | 2 |
| GENZYME CORPORATION | $30.59 | 1 |
| Avanos Medical | $17.08 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.63 | 1 |
| Acerta Pharma LLC | $15.94 | 1 |
| PFIZER INC. | $15.09 | 1 |
| Novo Nordisk AS | $13.16 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $308.03 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.85 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106953915 | CMS |
| ABBVIE INC. | $21.32 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106953917 | CMS |
| Alexion Pharmaceuticals, Inc. | $16.63 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093901989 | CMS |
| Amgen Inc. | $17.88 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115530681 | CMS |
| Amgen Inc. | $17.41 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115530695 | CMS |
| Amgen Inc. | $19.27 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117531926 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.94 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105581140 | CMS |
| Avanos Medical | $17.08 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149310155 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.73 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101320130 | CMS |
| E.R. Squibb & Sons, L.L.C. | $30.44 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101320152 | CMS |
| GENZYME CORPORATION | $30.59 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139932717 | CMS |
| Novo Nordisk Inc | $13.16 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100656703 | CMS |
| PFIZER INC. | $15.09 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131122701 | CMS |
| UCB, Inc. | $15.95 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143483376 | CMS |
| UCB, Inc. | $18.23 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143483382 | CMS |
| UCB, Inc. | $16.46 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143483388 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.